Owner Gala Design, Inc.

Inventors Bleck, Gregory T

Agent Spruson & Ferguson

Pub. Number AU-B-2001270252

PCT Pub. Number WO02/02783

Priority 60/215,851 03.07.00 US; 09/897,006 29.06.01 US

Filing date 29 June 2001

Wipo publication date 14 January 2002

Acceptance publication date 8 February 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/867 (2006.01) Mutation or genetic engineering - Retroviral vectors

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases